MicroRNAs as new players for diagnosis, prognosis, and therapeutic targets in breast cancer

Journal of Oncology

Volumn , Issue , 2009, Pages

  Kwong, Ava ^a   Ng, Enders K O ^a   Wong, Chris L P ^b   Ma, Edmond S K ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GEFITINIB; LAPATINIB; MICRORNA; MICRORNA 10B; MICRORNA 125A; MICRORNA 125B; MICRORNA 17 5P; MICRORNA 205; MICRORNA 206; MICRORNA 21; MICRORNA 27A; MICRORNA LET 7; TAMOXIFEN; TRASTUZUMAB; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; GENE EXPRESSION; GENE TARGETING; HUMAN; PROGNOSIS; REVIEW;

EID: 68949142739     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/305420     Document Type: Review

References (55)

1. Calin G. A., Croce C. M., MicroRNA signatures in human cancers Nature Reviews Cancer 2006 6 11 857 866
2. He L., Thomson J. M., Hemann M. T., A microRNA polycistron as a potential human oncogene Nature 2005 435 7043 828 833
3. He L., Hannon G. J., MicroRNAs: small RNAs with a big role in gene regulation Nature Reviews Genetics 2004 5 7 522 531
4. Chen C.-Z., MicroRNAs as oncogenes and tumor suppressors The New England Journal of Medicine 2005 353 1768 1771
5. Takamizawa J., Konishi H., Yanagisawa K., Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Research 2004 64 11 3753 3756
6. Cimmino A., Calin G. A., Fabbri M., miR-15 and miR-16 induce apoptosis by targeting BCL2 Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 13944 13949
7. ODonnell K. A., Wentzel E. A., Zeller K. I., Dang C. V., Mendell J. T., c-Myc-regulated microRNAs modulate E2F1 expression Nature 2005 435 7043 839 843
8. Kent O. A., Mendell J. T., A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes Oncogene 2006 25 46 6188 6196
9. Iorio M. V., Ferracin M., Liu C.-G., MicroRNA gene expression deregulation in human breast cancer Cancer Research 2005 65 16 7065 7070
10. Volinia S., Calin G. A., Liu C.-G., A microRNA expression signature of human solid tumors defines cancer gene targets Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2257 2261
11. Lu J., Getz G., Miska E. A., MicroRNA expression profiles classify human cancers Nature 2005 435 7043 834 838
12. Blenkiron C., Goldstein L. D., Thorne N. P., MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biology 2007 8 10, article R214
13. Foekens J. A., Sieuwerts A. M., Smid M., Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13021 13026
14. Lu Z., Liu M., Stribinskis V., MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene Oncogene 2008 27 31 4373 4379
15. Si M.-L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.-Y., miR-21-mediated tumor growth Oncogene 2007 26 19 2799 2803
16. Yan L.-X., Huang X.-F., Shao Q., MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis RNA 2008 14 11 2348 2360
17. Zhu S., Si M.-L., Wu H., Mo Y.-Y., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) The Journal of Biological Chemistry 2007 282 19 14328 14336
18. Wickramasinghe N. S., Manavalan T. T., Dougherty S. M., Riggs K. A., Li Y., Klinge C. M., Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Research 2009 37 8 2584 2595
19. Frankel L. B., Christoffersen N. R., Jacobsen A., Lindow M., Krogh A., Lund A. H., Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells The Journal of Biological Chemistry 2008 283 2 1026 1033
20. Ma L., Teruya-Feldstein J., Weinberg R. A., Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 2007 449 7163 682 688
21. Mertens-Talcott S. U., Chintharlapalli S., Li X., Safe S., The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells Cancer Research 2007 67 22 11001 11011
22. Kondo N., Toyama T., Sugiura H., Fujii Y., Yamashita H., miR-206 expression is down-regulated in estrogen receptor -positive human breast cancer Cancer Research 2008 68 13 5004 5008
23. Adams B. D., Furneaux H., White B. A., The microribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines Molecular Endocrinology 2007 21 1132 1147
24. Hossain A., Kuo M. T., Saunders G. F., Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA Molecular and Cellular Biology 2006 26 21 8191 8201
25. Scott G. K., Goga A., Bhaumik D., Berger C. E., Sullivan C. S., Benz C. C., Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b The Journal of Biological Chemistry 2007 282 2 1479 1486
26. Yu F., Yao H., Zhu P., let -7 regulates self renewal and tumorigenicity of breast cancer cells Cell 2007 131 6 1109 1123
27. Hurst D. R., Edmonds M. D., Scott G. K., Benz C. C., Vaidya K. S., Welch D. R., Breast cancer metastasis suppressor 1 up-regulates miR-146, Which suppresses breast cancer metastasis Cancer Research 2009 69 4 1279 1283
28. Calin G. A., Ferracin M., Cimmino A., A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia The New England Journal of Medicine 2005 353 17 1793 1801
29. Li Z., Lu J., Sun M., Distinct microRNA expression profiles in acute myeloid leukemia with common translocations Proceedings of the National Academy of Sciences of the United States of America 2008 105 40 15535 15540
30. Yanaihara N., Caplen N., Bowman E., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 2006 9 3 189 198
31. Iorio M. V., Casalini P., Tagliabue E., Menard S., Croce C. M., MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer European Journal of Cancer 2008 44 18 2753 2759
32. Lowery A. J., Miller N., McNeill R. E., Kerin M. J., MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management Clinical Cancer Research 2008 14 2 360 365
33. Camps C., Buffa F. M., Colella S., Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer Clinical Cancer Research 2008 14 5 1340 1348
34. Tavazoie S. F., Alarcon C., Oskarsson T., Endogenous human microRNAs that suppress breast cancer metastasis Nature 2008 451 7175 147 152
35. Wong T.-S., Liu X.-B., Wong B. Y.-H., Ng R. W.-M., Yuen A. P.-W., Wei W. I., Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue Clinical Cancer Research 2008 14 9 2588 2592
36. Chen X., Ba Y., Ma L., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Research 2008 18 10 997 1006
37. Mitchell P. S., Parkin R. K., Kroh E. M., Circulating microRNAs as stable blood-based markers for cancer detection Proceedings of the National Academy of Sciences of the United States of America 2008 105 10513 10518
38. Resnick K. E., Alder H., Hagan J. P., Richardson D. L., Croce C. M., Cohn D. E., The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform Gynecologic Oncology 2009 112 1 55 59
39. Ng E. K., Chong W. W., Jin H. C., Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut. In press
40. Kovalchuk O., Filkowski J., Meservy J., Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Molecular Cancer Therapeutics 2008 7 7 2152 2159
41. Crowder R. J., Lombardi D. P., Ellis M. J., Successful targeting of ErbB2 receptorsis PTEN the key? Cancer Cell 2004 6 2 103 104
42. Nahta R., Takahashi T., Ueno N. T., Hung M.-C., Esteva F. J., P 27 kip 1 down-regulation is associated with trastuzumab resistance in breast cancer cells Cancer Research 2004 64 11 3981 3986 (Pubitemid 38697313)
43. Galardi S., Mercatelli N., Giorda E., miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 The Journal of Biological Chemistry 2007 282 32 23716 23724
44. Visone R., Russo L., Pallante P., MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle Endocrine-Related Cancer 2007 14 3 791 798
45. Chang T.-C., Wentzel E. A., Kent O. A., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Molecular Cell 2007 26 5 745 752
46. He L., He X., Lim L. P., A microRNA component of the p53 tumour suppressor network Nature 2007 447 7148 1130 1134
47. Weidhaas J. B., Babar I., Nallur S. M., MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy Cancer Research 2007 67 23 11111 11116
48. Jemal A., Siegel R., Ward E., Cancer statistics, 2006 CA: A Cancer Journal for Clinicians 2006 56 2 106 130
49. Hasemeier B., Christgen M., Kreipe H., Lehmann U., Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology BMC Biotechnology 2008 8, article 90
50. Chim S. S. C., Shing T. K. F., Hung E. C. W., Detection and characterization of placental microRNAs in maternal plasma Clinical Chemistry 2008 54 3 482 490
51. Brummelkamp T. R., Bernards R., Agami R., A system for stable expression of short interfering RNAs in mammalian cells Science 2002 296 5567 550 553
52. Birmingham A., Anderson E. M., Reynolds A., 3 ′ UTR seed matches, but not overall identity, are associated with RNAi off-targets Nature Methods 2006 3 3 199 204
53. Anderson E. M., Birmingham A., Baskerville S., Experimental validation of the importance of seed complement frequency to siRNA specificity RNA 2008 14 5 853 861
54. Jackson A. L., Burchard J., Leake D., Position-specific chemical modification of siRNAs reduces off-target transcript silencing RNA 2006 12 7 1197 1205
55. Burchard J., Jackson A. L., Malkov V., MicroRNA-like off-target transcript regulation by siRNAs is species specific RNA 2009 15 2 308 315